The U.S. FDA announced 19 new grants and two new contracts totaling more than $38 million in funding over the next four years to support clinical trials, natural history studies and regulatory science tools related to rare diseases....
Ricki Fairley, the founder and CEO of Touch, the Black Breast Cancer Alliance in Annapolis, discusses how she created a whole new life for herself after her breast cancer diagnosis and how her nonprofit aims to change the way the world looks at Black women...
The lasting impacts of the COVID-19 pandemic will be felt for decades to come, and some of those impacts aren’t fully understood yet, especially among communities of color and the elderly....
As part of its commitment to clinical research workforce development, ACRP is offering a new scholarship program to support clinical researchers on their pathway toward a master’s degree in clinical research....
Check out some photos from the inaugural Wisconsin Collaborative Clinical Research Professionals Conference at UW–Madison....
Michaele Linden-Johnson is at the helm of a program designed to better serve the health and clinical trial needs of her nearly 90% Hispanic patient population in and around El Paso, Texas....
The Wisconsin Collaborative Clinical Research Professionals Conference will provide opportunities for clinical research professionals to engage with one another, as well as students, community leaders and industry, including representatives from Epic Systems and Exact Sciences....
On its 20th anniversary, UW–Madison's M.S. in Biotech program continues to build Wisconsin's biosciences industry, prepare students to drive the industry forward, establish strong industry partnerships and advance life-saving discoveries....
UW Health's Dr. Sandesh Parajuli is conducting a first-of-its-kind clinicaltrial that uses T-cells from a donor to treat BK virus infection that can arise from the immunosuppression required for kidney transplant patients....
According to GlobalData’s Clinical Trial Database, six out of the 11 planned trials disclosed in the last two weeks will be investigating Covid-19 boosters and therapeutics....
